Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

UGT2B7_-161C>T polymorphism is associated with lamotrigine concentration-to-dose ratio in a multivariate study.

Blanca Sánchez M, Herranz JL, Leno C, Arteaga R, Oterino A, Valdizán EM, Nicolas JM, Adín J, Shushtarian M, Armijo JA.

Ther Drug Monit. 2010 Apr;32(2):177-84. doi: 10.1097/FTD.0b013e3181ceecc6.

PMID:
20216122
2.

Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients.

Singkham N, Towanabut S, Lertkachatarn S, Punyawudho B.

Eur J Clin Pharmacol. 2013 Jun;69(6):1285-91. doi: 10.1007/s00228-012-1449-5. Epub 2012 Dec 21.

PMID:
23263737
3.

Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children.

Liu L, Zhao L, Wang Q, Qiu F, Wu X, Ma Y.

Eur J Clin Pharmacol. 2015 Nov;71(11):1341-7. doi: 10.1007/s00228-015-1925-9. Epub 2015 Aug 26.

PMID:
26303110
5.

Effects of UGT2B7 genetic polymorphisms on serum concentrations of valproic acid in Chinese epileptic children comedicated with lamotrigine.

Wang Q, Liang M, Dong Y, Yun W, Qiu F, Meng H, Zhao L, Guo Y.

Ther Drug Monit. 2015 Dec 29. [Epub ahead of print]

PMID:
26717295
6.

Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.

May TW, Rambeck B, Jürgens U.

Ther Drug Monit. 1996 Oct;18(5):523-31.

PMID:
8885114
7.

Lamotrigine serum concentration-to-dose ratio: influence of age and concomitant antiepileptic drugs and dosage implications.

Armijo JA, Bravo J, Cuadrado A, Herranz JL.

Ther Drug Monit. 1999 Apr;21(2):182-90.

PMID:
10217338
8.

The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy.

Gulcebi MI, Ozkaynakcı A, Goren MZ, Aker RG, Ozkara C, Onat FY.

Epilepsy Res. 2011 Jun;95(1-2):1-8. doi: 10.1016/j.eplepsyres.2011.01.016. Epub 2011 May 20.

PMID:
21601426
10.

Influence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients.

Inoue K, Suzuki E, Yazawa R, Yamamoto Y, Takahashi T, Takahashi Y, Imai K, Koyama S, Inoue Y, Tsuji D, Hayashi H, Itoh K.

Ther Drug Monit. 2014 Jun;36(3):406-9. doi: 10.1097/FTD.0000000000000012.

PMID:
24365988
11.

Correlation of the UGT1A4 gene polymorphism with serum concentration and therapeutic efficacy of lamotrigine in Han Chinese of Northern China.

Chang Y, Yang LY, Zhang MC, Liu SY.

Eur J Clin Pharmacol. 2014 Aug;70(8):941-6. doi: 10.1007/s00228-014-1690-1. Epub 2014 May 13.

PMID:
24820767
12.

Pharmacogenetics of the antiepileptic drugs phenytoin and lamotrigine.

López M, Dorado P, Monroy N, Alonso ME, Jung-Cook H, Machín E, Peñas-Lledó E, Llerena A.

Drug Metabol Drug Interact. 2011;26(1):5-12. doi: 10.1515/DMDI.2011.008. Review.

PMID:
21557672
13.

Does lamotrigine influence valproate concentrations?

Mataringa MI, May TW, Rambeck B.

Ther Drug Monit. 2002 Oct;24(5):631-6.

PMID:
12352935
14.

Drug interactions between lamotrigine and psychoactive drugs: evidence from a therapeutic drug monitoring service.

Reimers A, Skogvoll E, Sund JK, Spigset O.

J Clin Psychopharmacol. 2005 Aug;25(4):342-8.

PMID:
16012277
15.

Time course of lamotrigine de-induction: impact of step-wise withdrawal of carbamazepine or phenytoin.

Anderson GD, Gidal BE, Messenheimer JA, Gilliam FG.

Epilepsy Res. 2002 May;49(3):211-7.

PMID:
12076842
16.

In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction.

Rowland A, Elliot DJ, Williams JA, Mackenzie PI, Dickinson RG, Miners JO.

Drug Metab Dispos. 2006 Jun;34(6):1055-62. Epub 2006 Mar 24.

17.

Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy.

Inoue K, Yamamoto Y, Suzuki E, Takahashi T, Umemura A, Takahashi Y, Imai K, Inoue Y, Hirai K, Tsuji D, Itoh K.

Eur J Clin Pharmacol. 2016 Jan 20. [Epub ahead of print]

PMID:
26790665
18.

Lamotrigine and valproate pharmacokinetics interactions in epileptic patients.

Lalic M, Cvejic J, Popovic J, Bozic K, Golocorbin-Kon S, Al-Salami H, Mikov M.

Eur J Drug Metab Pharmacokinet. 2009 Apr-Jun;34(2):93-9.

PMID:
19645218
19.

Influence of concomitant antiepileptic drugs on plasma lamotrigine concentration in adult Japanese epilepsy patients.

Yamamoto Y, Inoue Y, Matsuda K, Takahashi Y, Kagawa Y.

Biol Pharm Bull. 2012;35(4):487-93.

20.

10-Hydroxycarbazepine serum concentration-to-oxcarbazepine dose ratio: influence of age and concomitant antiepileptic drugs.

Armijo JA, Vega-Gil N, Shushtarian M, Adín J, Herranz JL.

Ther Drug Monit. 2005 Apr;27(2):199-204.

PMID:
15795652
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk